Just two pages before Manasseh and colleagues’ article about conjunctivitis in newborns1 in the print issue of 2 […]
Researchers found that less than half of Americans who received treatment for opioid use disorder over a five-year […]
A new research project at Leuphana University Lüneburg is dealing with digital contact tracing for the containment of […]
Fagron, a leading global company active in pharmaceutical compounding, announced on April 14th the acquisition of HiperScan, the […]
bmj;377/may10_13/o1165/FAF1faAnas AlkharboutliThe International Rescue Committee is highlighting the plight of women and girls in the world’s conflict zones […]
I would argue for caution in interpreting the public health impact against dementia of Dhana and colleagues’ encouraging […]
“You’ve really been through it,” the midwife said after we had finally been discharged from hospital. It was […]
In this paper by Cram and colleagues (BMJ 2022;377:069164, doi:10.1136/bmj-2021-069164, published 4 May 2022), some of the acknowledgments […]
NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy
Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes